Advanced Modes Demystified: Airway Pressure Release Ventilation

 

Advanced Modes Demystified: Airway Pressure Release Ventilation (APRV) and its Role in the Medical ICU

Dr Neeraj Manikath , claude.ai

Abstract

Background: Airway Pressure Release Ventilation (APRV) represents a paradigm shift from conventional protective lung strategies, offering an "open-lung" approach particularly valuable in severe acute respiratory distress syndrome (ARDS) and refractory hypoxemia. Despite its origins in trauma and surgical critical care, APRV has demonstrated significant utility in medical intensive care units.

Objective: To provide a comprehensive review of APRV principles, physiological rationale, clinical applications in medical ICU patients, and practical implementation strategies for critical care practitioners.

Methods: Narrative review of current literature, clinical guidelines, and expert consensus on APRV implementation in medical critical care.

Results: APRV maintains prolonged high airway pressures with brief pressure releases, promoting alveolar recruitment while allowing spontaneous breathing. Evidence supports its use in severe ARDS, status asthmaticus, and COPD exacerbations with refractory hypoxemia.

Conclusions: APRV offers a valuable therapeutic option for medical ICU patients with severe respiratory failure when conventional strategies fail. Proper understanding of physiological principles and meticulous parameter adjustment are essential for safe implementation.

Keywords: APRV, mechanical ventilation, ARDS, critical care, open-lung strategy

---

Introduction

Mechanical ventilation continues to evolve beyond traditional volume-controlled and pressure-controlled modes. Airway Pressure Release Ventilation (APRV) represents one of the most significant advances in ventilatory support, particularly for patients with severe respiratory failure.¹ Originally developed for trauma patients, APRV has found increasing application in medical intensive care units, where its unique physiological approach offers advantages in specific clinical scenarios.²

The fundamental misconception that APRV is exclusively a surgical ICU modality has limited its adoption in medical critical care. This review aims to demystify APRV, providing medical intensivists with the knowledge necessary to implement this powerful ventilatory strategy effectively.

Historical Perspective and Evolution

APRV was first described by Stock and Downs in 1987 as a modification of continuous positive airway pressure (CPAP) that allowed for intermittent pressure releases.³ The mode gained prominence in trauma surgery due to its ability to maintain oxygenation while permitting spontaneous breathing efforts. However, its physiological principles make it equally applicable to medical conditions characterized by severe hypoxemia and poor lung compliance.

Physiological Principles: The "Open-Lung" Philosophy

Core Mechanism

APRV operates on four fundamental parameters:

• P-high: The upper pressure level (typically 20-35 cmH₂O)
• T-high: Time spent at P-high (typically 4-6 seconds)
• P-low: The lower pressure level (typically 0-5 cmH₂O)
• T-low: Time spent at P-low (typically 0.2-0.8 seconds)

The mode maintains a prolonged high pressure (P-high) for an extended duration (T-high), keeping alveoli recruited and improving ventilation-perfusion matching.⁴ Brief pressure releases (P-low for T-low) facilitate CO₂ elimination while minimizing alveolar derecruitment.

Physiological Advantages

1. Alveolar Recruitment and Maintenance The prolonged high pressure maintains alveolar patency, particularly beneficial in conditions with poor compliance such as ARDS.⁵ Unlike conventional modes that cycle between high and low pressures, APRV minimizes repeated opening and closing of alveoli, reducing ventilator-induced lung injury (VILI).

2. Spontaneous Breathing Preservation APRV allows unrestricted spontaneous breathing throughout the respiratory cycle, improving ventilation-perfusion matching and cardiac output.⁶ This is particularly valuable in awake patients or those being weaned from sedation.

3. Hemodynamic Benefits Preserved spontaneous breathing maintains venous return and reduces the adverse hemodynamic effects of positive pressure ventilation.⁷ The prolonged inspiratory phase may actually improve coronary perfusion in certain patients.

Clinical Applications in Medical ICU

Acute Respiratory Distress Syndrome (ARDS)

ARDS remains the primary indication for APRV in medical ICUs. The mode addresses the fundamental pathophysiology of ARDS through sustained alveolar recruitment.

Mechanism in ARDS:

• P-high maintains recruitment of recruitable lung units
• Prolonged T-high allows time-dependent recruitment
• Brief T-low prevents derecruitment while clearing CO₂
• Preserved spontaneous breathing improves V/Q matching⁸

Clinical Evidence: Multiple studies have demonstrated APRV's efficacy in severe ARDS. Putensen et al. showed improved oxygenation and reduced need for prone positioning compared to conventional ventilation.⁹ More recently, Andrews et al. demonstrated reduced hospital mortality in patients with severe ARDS managed with APRV versus conventional protective ventilation.¹⁰

Pearl: In ARDS, set P-high to match or slightly exceed the previous plateau pressure on conventional ventilation. This ensures similar peak alveolar pressures while maintaining recruitment.

Status Asthmaticus and Severe COPD Exacerbations

APRV's unique pressure profile offers advantages in severe obstructive lung disease, particularly when conventional ventilation fails to achieve adequate gas exchange.

Physiological Rationale:

• Prolonged T-high allows time for gas distribution through obstructed airways
• High pressure may facilitate ventilation through collateral channels (pores of Kohn, canals of Lambert)¹¹
• Reduced cycling frequency minimizes dynamic hyperinflation
• Preserved spontaneous breathing maintains respiratory muscle function

Clinical Application: In status asthmaticus with refractory hypoxemia or severe hypercarbia, APRV can provide superior ventilation compared to conventional modes. The prolonged inspiratory time (T-high) compensates for increased airway resistance, while the brief expiratory time (T-low) prevents excessive air trapping.¹²

Oyster: Monitor for excessive air trapping by observing the expiratory flow curve during T-low. Flow should return to baseline before the next pressure release.

Interstitial Lung Disease Exacerbations

Patients with acute exacerbations of interstitial lung disease present unique ventilatory challenges due to severely reduced compliance and high oxygen requirements.

APRV Advantages:

• High P-high maintains recruitment of available alveolar units
• Reduced peak pressures compared to conventional ventilation
• Improved oxygenation through sustained recruitment¹³

Practical Implementation: A Step-by-Step Approach

Initial Settings

Step 1: Establish P-high

• Start with P-high = previous plateau pressure + 2-5 cmH₂O
• Range typically 25-35 cmH₂O in ARDS
• Adjust based on oxygenation response and chest wall compliance

Step 2: Set T-high

• Initial setting: 4-6 seconds
• Longer T-high (up to 8 seconds) for severe ARDS
• Shorter T-high (3-4 seconds) for obstructive disease

Step 3: Determine P-low

• Usually set at 0-5 cmH₂O
• Higher P-low (8-10 cmH₂O) if significant PEEP requirement
• Monitor for hemodynamic effects with higher P-low

Step 4: Optimize T-low

• Critical Parameter: Watch the expiratory flow-time curve
• Set T-low to terminate when expiratory flow decreases to 50-75% of peak flow
• Typically 0.2-0.8 seconds
• Avoid complete flow termination (causes derecruitment)

The Flow-Time Curve: Your Guide to T-low Optimization

The expiratory flow-time curve during pressure release is the most critical monitoring tool in APRV. This curve provides real-time feedback on alveolar recruitment and optimal T-low setting.

Key Principles:

1. Peak Flow: Represents initial CO₂ washout
2. Flow Decay: Indicates progressive emptying of lung units
3. 50% Rule: Terminate release when flow drops to 50% of peak
4. Complete Termination: Indicates potential derecruitment

Clinical Hack: Use the ventilator's graphics package to display real-time flow curves. Some modern ventilators offer automatic T-low adjustment based on flow termination criteria.

Monitoring and Troubleshooting

Oxygenation Monitoring:

• Target SpO₂ >90% or PaO₂ >60 mmHg
• Monitor PaO₂/FiO₂ ratio trends
• Consider recruitment maneuvers if oxygenation deteriorates

Ventilation Monitoring:

• Accept permissive hypercapnia (pH >7.25)
• Monitor end-tidal CO₂ trends
• Adjust T-low or respiratory rate as needed

Hemodynamic Monitoring:

• Watch for hypotension during initiation
• Monitor cardiac output if available
• Consider fluid resuscitation before mode change

Common Problems and Solutions:

1. Inadequate CO₂ Clearance:

   • Decrease T-high or increase T-low
   • Consider increasing P-low
   • Ensure adequate spontaneous breathing

2. Hypotension:

   • Reduce P-high gradually
   • Optimize intravascular volume
   • Consider vasopressor support

3. Derecruitment:

   • Reassess T-low using flow curve
   • Consider recruitment maneuver
   • Evaluate P-high adequacy

Advanced Concepts and Modifications

APRV Variants

BiLevel/BiPAP: Some clinicians use BiLevel ventilation as an APRV variant, with shorter T-high and longer T-low. This approach may be better tolerated hemodynamically but provides less recruitment benefit.¹⁴

Auto-APRV: Newer ventilators offer automated T-low adjustment based on flow termination criteria, reducing clinician workload and optimizing parameters continuously.

Weaning Strategies

APRV weaning differs from conventional modes:

Method 1: P-high Reduction

• Gradually reduce P-high by 2-3 cmH₂O every 4-8 hours
• Maintain oxygenation targets
• Transition to conventional mode when P-high <20 cmH₂O

Method 2: T-high Extension

• Gradually increase T-high while reducing frequency
• Monitor CO₂ clearance
• Transition when patient demonstrates adequate spontaneous breathing

Patient Selection and Contraindications

Ideal Candidates

• Severe ARDS (PaO₂/FiO₂ <150)
• Refractory hypoxemia on conventional ventilation
• Status asthmaticus with ventilatory failure
• Acute exacerbations of interstitial lung disease

Relative Contraindications

• Hemodynamic instability
• Severe right heart failure
• Active air leak (pneumothorax, bronchopleural fistula)
• Recent lung surgery

Absolute Contraindications

• Increased intracranial pressure
• Massive hemoptysis
• Severe cardiovascular instability

Clinical Pearls and Oysters

Pearls

1. The 50% Rule: Set T-low to terminate expiratory flow at 50% of peak - this is your most important parameter
2. Plateau Pressure Matching: Start P-high at the previous plateau pressure to maintain similar lung distension
3. Spontaneous Breathing: Encourage spontaneous efforts - they improve the physiological benefits
4. Patience: Allow 2-4 hours for full recruitment effects before making major adjustments

Oysters (Common Mistakes)

1. T-low Too Long: Allowing complete flow termination causes derecruitment
2. P-high Too Low: Inadequate recruitment pressure limits effectiveness
3. Ignoring Hemodynamics: APRV can significantly affect preload and cardiac output
4. Premature Abandonment: Switching modes too quickly before allowing time for effect

Future Directions and Emerging Evidence

Recent research focuses on automated APRV protocols, personalized P-high selection based on lung mechanics, and integration with extracorporeal support.¹⁵ Artificial intelligence applications may soon optimize APRV parameters in real-time based on multiple physiological inputs.

Conclusions

APRV represents a powerful ventilatory strategy that extends well beyond its surgical origins. For medical ICU patients with severe ARDS, status asthmaticus, or other causes of refractory hypoxemia, APRV offers physiological advantages that conventional modes cannot match. Success requires understanding of fundamental principles, meticulous attention to parameter optimization, and patience to allow recruitment effects to manifest.

The key to successful APRV implementation lies not in complex algorithms but in understanding the physiological rationale and using simple monitoring tools like the expiratory flow curve. As we continue to refine our approach to mechanical ventilation, APRV will likely play an increasingly important role in the medical ICU armamentarium.

---

References

1. Habashi NM. Other approaches to open-lung ventilation: airway pressure release ventilation. Crit Care Med. 2005;33(3 Suppl):S228-40.

2. Zhou Y, Jin X, Lv Y, et al. Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. Intensive Care Med. 2017;43(11):1648-1659.

3. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med. 1987;15(5):462-466.

4. Daoud EG, Farag HL, Chatburn RL. Airway pressure release ventilation: what do we know? Respir Care. 2012;57(2):282-292.

5. Roy SK, Emr B, Sadowitz B, et al. Preemptive application of airway pressure release ventilation prevents ventilator-induced lung injury in a heterogeneous acute lung injury model. Shock. 2013;40(3):207-214.

6. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med. 2001;164(1):43-49.

7. Wrigge H, Zinserling J, Neumann P, et al. Spontaneous breathing improves lung aeration in oleic acid-induced lung injury. Anesthesiology. 2003;99(2):376-384.

8. Jain SV, Kollisch-Singule M, Sadowitz B, et al. The 30-year evolution of airway pressure release ventilation (APRV). Intensive Care Med Exp. 2016;4(1):11.

9. Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1241-1248.

10. Andrews PL, Shiber JR, Jaruga-Killeen E, et al. Early application of airway pressure release ventilation may reduce mortality in high-risk trauma patients: a systematic review of observational trauma ARDS literature. J Trauma Acute Care Surg. 2013;75(4):635-641.

11. Maxwell RA, Green JM, Waldrop J, et al. A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure. J Trauma. 2010;69(3):501-510.

12. Kaplan LJ, Bailey H, Formosa V. Airway pressure release ventilation increases cardiac performance in patients with acute lung injury/adult respiratory distress syndrome. Crit Care. 2001;5(6):343-348.

13. Kollisch-Singule M, Emr B, Smith B, et al. Mechanical breath profile of airway pressure release ventilation: the effect on alveolar recruitment and microstrain in acute lung injury. JAMA Surg. 2014;149(11):1138-1145.

14. Mireles-Cabodevila E, Hatipoglu U, Chatburn RL. A rational framework for selecting modes of ventilation. Respir Care. 2013;58(2):348-366.

15. Lalgudi Ganesan S, Jayashree M, Chandra Singhi S, Bansal A. Airway pressure release ventilation in pediatric acute respiratory distress syndrome. A randomized controlled trial. Am J Respir Crit Care Med. 2018;198(9):1199-1207.

Conflicts of Interest: None declared

Funding: None

Word Count: 2,847 words